19-14100864-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_002730.4(PRKACA):c.381G>A(p.Gly127Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000787 in 1,614,174 control chromosomes in the GnomAD database, including 16 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.00098 ( 4 hom., cov: 32)
Exomes 𝑓: 0.00077 ( 12 hom. )
Consequence
PRKACA
NM_002730.4 synonymous
NM_002730.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.303
Publications
4 publications found
Genes affected
PRKACA (HGNC:9380): (protein kinase cAMP-activated catalytic subunit alpha) This gene encodes one of the catalytic subunits of protein kinase A, which exists as a tetrameric holoenzyme with two regulatory subunits and two catalytic subunits, in its inactive form. cAMP causes the dissociation of the inactive holoenzyme into a dimer of regulatory subunits bound to four cAMP and two free monomeric catalytic subunits. Four different regulatory subunits and three catalytic subunits have been identified in humans. cAMP-dependent phosphorylation of proteins by protein kinase A is important to many cellular processes, including differentiation, proliferation, and apoptosis. Constitutive activation of this gene caused either by somatic mutations, or genomic duplications of regions that include this gene, have been associated with hyperplasias and adenomas of the adrenal cortex and are linked to corticotropin-independent Cushing's syndrome. Alternative splicing results in multiple transcript variants encoding different isoforms. Tissue-specific isoforms that differ at the N-terminus have been described, and these isoforms may differ in the post-translational modifications that occur at the N-terminus of some isoforms. [provided by RefSeq, Jan 2015]
PRKACA Gene-Disease associations (from GenCC):
- cardioacrofacial dysplasia 1Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- Ellis-van Creveld syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- pigmented nodular adrenocortical disease, primary, 4Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.43).
BP6
Variant 19-14100864-C-T is Benign according to our data. Variant chr19-14100864-C-T is described in ClinVar as Benign. ClinVar VariationId is 731258.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.303 with no splicing effect.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.000978 (149/152346) while in subpopulation EAS AF = 0.0227 (118/5188). AF 95% confidence interval is 0.0194. There are 4 homozygotes in GnomAd4. There are 85 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 4 AD,AR,Unknown gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PRKACA | NM_002730.4 | c.381G>A | p.Gly127Gly | synonymous_variant | Exon 5 of 10 | ENST00000308677.9 | NP_002721.1 | |
| PRKACA | NM_001304349.2 | c.609G>A | p.Gly203Gly | synonymous_variant | Exon 5 of 10 | NP_001291278.1 | ||
| PRKACA | NM_207518.3 | c.357G>A | p.Gly119Gly | synonymous_variant | Exon 5 of 10 | NP_997401.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000985 AC: 150AN: 152228Hom.: 4 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
150
AN:
152228
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00157 AC: 395AN: 251378 AF XY: 0.00151 show subpopulations
GnomAD2 exomes
AF:
AC:
395
AN:
251378
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000767 AC: 1121AN: 1461828Hom.: 12 Cov.: 30 AF XY: 0.000840 AC XY: 611AN XY: 727212 show subpopulations
GnomAD4 exome
AF:
AC:
1121
AN:
1461828
Hom.:
Cov.:
30
AF XY:
AC XY:
611
AN XY:
727212
show subpopulations
African (AFR)
AF:
AC:
0
AN:
33480
American (AMR)
AF:
AC:
1
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26134
East Asian (EAS)
AF:
AC:
749
AN:
39698
South Asian (SAS)
AF:
AC:
162
AN:
86256
European-Finnish (FIN)
AF:
AC:
1
AN:
53416
Middle Eastern (MID)
AF:
AC:
6
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
121
AN:
1111964
Other (OTH)
AF:
AC:
81
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
53
107
160
214
267
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000978 AC: 149AN: 152346Hom.: 4 Cov.: 32 AF XY: 0.00114 AC XY: 85AN XY: 74494 show subpopulations
GnomAD4 genome
AF:
AC:
149
AN:
152346
Hom.:
Cov.:
32
AF XY:
AC XY:
85
AN XY:
74494
show subpopulations
African (AFR)
AF:
AC:
1
AN:
41580
American (AMR)
AF:
AC:
1
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
118
AN:
5188
South Asian (SAS)
AF:
AC:
17
AN:
4830
European-Finnish (FIN)
AF:
AC:
1
AN:
10618
Middle Eastern (MID)
AF:
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
AC:
10
AN:
68040
Other (OTH)
AF:
AC:
0
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
6
13
19
26
32
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
45
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.